Public annual accounts

NEOPLAST financials

Name: NEOPLAST financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for NEOPLAST, with comparable measures and links to available source documents.

Company overview

Registry number

0821712437

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for NEOPLAST

2025 versus 2024

Operating line: €513,494
EBITDA: €502,753
Total assets: €4,586,869
Equity: €4,495,689

EBITDA margin +97.9% · Equity ratio +98%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€513,494	€502,753	€4,586,869	€4,495,689	-
202431 Dec 2024	€422,851	€411,206	€4,387,854	€4,385,879	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report